Serina Therapeutics, Inc. (SER) AMEX
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 19.46M |
| Enterprise Value | 16.6M |
| P/E Ratio | -1.01 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 165 |
| Price/Book Ratio | 1.35 |
| Enterprise/Revenue | 0.72 |
| Enterprise/EBITDA | -0 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -163.59 |
| Operating Margin | -188.03 |
| Return On Assets | -0.78 |
| Return On Equity | -4.02 |
| Revenue | 0 |
| Revenue/Share | 0.01 |
| Gross Profit | 0 |
| EBITDA | -18.91M |
| Net Income | -19.18M |
| Diluted EPS | -1.91 |
| Total Cash | 24.53M |
| Total Cash/Share | 2.04 |
| Total Debt | 3.17M |
| Total Debt/Equity | 0.18 |
| Current Ratio | 4.18 |
| Book Value Per Share | 1.46 |
| 52-Week Change | -62.71 |
| 52-Week High | 7.92 |
| 52-Week Low | 1.22 |
| Moving Average 50 Days | 1.87 |
| Moving Average 200 Days | 2.71 |
| Average Volume | 94,354 |
| Shares Outstanding | 10.83M |
| % Held by Institutions | 14.45 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 7:250 |
| Last Split Date | March 15, 2024 |